Quantum-chemical structure-affinity studies on kynurenic acid derivatives as Gly/NMDA receptor ligands

International Journal of Quantum Chemistry

Volumn 71, Issue 6, 1999, Pages 505-511

  Gómez Jeria, Juan Sebastian ^a   Lagos Arancibia, Luis ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2442478215     PISSN: 00207608     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-461X(1999)71:6<505::AID-QUA8>3.0.CO;2-H     Document Type: Article

References (35)

1. The NMDA Receptor; Watkins, J. C.; Collingridge, G. C., Eds.; Oxford University: London, 1989.
2. Stone, T. W. Pharmacol Rev 1993, 45, 309.
3. Nakanishi, S. Science 1992, 258, 597.
4. Olney, J. W. Annu Rev Pharmacol Toxicol 1990, 30, 47.
5. Meldrum, B. Cerebrovasc Brain Metab Rev 1990, 2, 27.
6. Johnson, J. W.; Ascher, P. Nature 1987, 325, 529.
7. Kemp, J. A.; Leeson, P. D. Trends Pharmacol Sci 1993, 14, 20.
8. Dingledine, R.; Kieckner, N. W.; McBain, C. J. In Excitatory Amino Acids and Neural Plasticity; Ben-Ari, Y., Ed.; Plenum: New York, 1990; pp 17-26.
9. Manallack, D. T.; Wong, M. G.; O'Shea, R. D.; Beart, P. M. Mol Neuropharmacol 1990, 1, 7.
10. Kessler, M.; Baudry, M.; Terranoui, T.; Lynch, G. Soc Neurosci Abstr 1987, 13, 760.
11. Watson, G. B.; Hood, W. F.; Monahan, J. B.; Lanthorn, T. H. Neurosci Res Commun 1988, 2, 169.
12. Kemp, J. A.; Foster, A. C.; Leeson, P. D.; Priestley, T.; Tridgett, R.; Iversen, L. L.; Woodruff, G. N. Proc Natl Acad Sci USA 1988, 85, 6547.
13. Leeson, P. D.; Baker, R.; Carling, R. W.; Curtis, N. R.; Moore, K. W.; Williams, B. J.; Foster, A. C.; Donald, A. E.; Kemp, J. A.; Marshall, G. R. J Med Chem 1991, 34, 1243.
14. Baron, B. M.; Harrison, B. L.; Miller, F. P.; McDonald, I. A.; Salituro, F. G.; Schmidt, C. J.; Sorensen, S. M.; White, H. S.; Palfreyman, M. G. J Med Chem 1990, 38, 554.
15. Moroni, F.; Alesiani, M.; Galli, A.; Mori, A.; Pecorari, A.; Carla, V.; Cherici, G.; Pellicciari, R. Eur J Pharmacol 1991, 199, 227.
16. Leeson, P. D.; Iversen, L. L. J Med Chem 1994, 37, 4053.
17. Gómez-Jeria, J. S. Int J Quantum Chem 1983, 23, 1969.
18. Gómez-Jeria, J. S. In Molecules in Physics, Chemistry and Biology; Maruani, J., Ed.; Kluwer: Dordrecht, 1989; Vol 4, pp 231-251.
19. Gómez-Jeria, J. S.; Morales-Lagos, D. In QSAR in Design of Bioactive Compounds; Kuchar, M., Ed.; J. R. Prous: Barcelona, 1984; pp 145-173.
20. Gómez-Jeria, J. S.; Cassels, B. K.; Saavedra-Aguilar, J. C. Eur J Med Chem 1987, 22, 433.
21. Góme-Jeria, J. S.; Ojeda-Vergara, M. Int J Quantum Chem 1997, 61, 997.
22. Gómez-Jeria, J. S.; Morales-Lagos, D.; Cassels, B. K.; Saavedra-Aguilar, J. C. Quantum Struct Act Relat 1986, 5, 153.
23. Gómez-Jeria, S.; Rodriguez-Gatica, J. I.; Morales-Lagos, D.; Saavedra-Aguilar, J. C. Int J Quantum Chem 1986, 28, 421.
24. Gómez-Jeria, J. S.; Sotomayor, P. J Mol Struct (Theochem) 1988, 166, 493.
25. Gómez-Jeria, J. S.; Donoso-Espinoza, C.; Ojeda-Vergara, M. Mol Engn 1995, 5, 391.
26. Gómez-Jeria, J. S. J Pharm Sci 1982, 71, 1423.
27. Contreras, R.; Gómez-Jeria, J. S. J Phys Chem 1984, 88, 1905.
28. Gómez-Jeria, J. S.; Contreras, R. Int J Quantum Chem 1986, 30, 581.
29. Gómez-Jeria, J. S.; Parra-Mouchet, J.; Morales-Lagos, D. J Mol Struct (Theochem) 1991, 236, 201.
30. Gómez-Jeria, J. S.; Parra-Mouchet, J.; Morales-Lagos, D. Int J Quantum Chem 1991, 40, 299.
31. Gómez-Jeria, J. S. Farmaco 1985, 40, 299.
32. Fukui, K.; Yonezawa, T.; Nagata, C.; Shingu, N. J Chem Phys 1954, 22, 1433.
33. Fukui, K.; Yonezawa, T.; Nagata, C. Bull Chem Soc 1954, 27, 423.
34. Fleming, I. Frontier Orbitals and Organic Chemical Reactions; Wiley: London, 1976.
35. Frontier Orbitals and Reaction Paths; Fukui, K.; Fujimoto, H., Eds.; World Scientific: Singapore, 1997.